Literature DB >> 1986032

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.

L C Groop1, C Saloranta, M Shank, R C Bonadonna, E Ferrannini, R A DeFronzo.   

Abstract

To investigate the mechanisms of insulin resistance in obesity and noninsulin-dependent diabetes mellitus (NIDDM), we examined oxidative and nonoxidative pathways of free fatty acid (FFA) and glucose metabolism in 14 lean and 17 obese (with normal oral glucose tolerance) nondiabetic subjects and in 8 lean and 8 obese subjects with NIDDM. FFA and glucose metabolism were measured using the sequential insulin clamp technique in combination with indirect calorimetry and infusion of [3-3H]glucose and [1-14C]palmitate. Obesity was characterized by enlarged fat mass, which correlated positively with the plasma FFA concentration (r = 0.62; P less than 0.01). FFA metabolism was less sensitive to insulin in obese than in lean nondiabetic subjects, but this defect could be overcome by increasing the plasma insulin concentration. NIDDM patients showed normal sensitivity to the inhibitory action of insulin on FFA metabolism; however, maximal suppression by insulin was impaired. The combination of obesity and NIDDM was associated with a further enhancement of reesterification of FFA than observed in either condition alone. In both obesity and NIDDM, the dose-response curve for suppression of hepatic glucose production by insulin was impaired. While obesity was primarily characterized by reduced sensitivity to the stimulatory action of insulin on oxidative and nonoxidative pathways of glucose metabolism, resistance to the effect of insulin on glucose metabolism in NIDDM was characterized by a reduced maximal response. The combination of obesity and NIDDM further impaired the sensitivity of liver glucose output and glucose oxidation to insulin. The hypothesis is advanced that in uncomplicated obesity, increased availability and oxidation of FFA leads, by the FFA/glucose cycle, to the impairment in glucose utilization. In NIDDM, on the other hand, the defect in glucose utilization is primary, and the enhanced rate of FFA oxidation may represent a compensatory phenomenon.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986032     DOI: 10.1210/jcem-72-1-96

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  66 in total

Review 1.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 2.  Metabolic and molecular basis of insulin resistance.

Authors:  Mandeep Bajaj; Ralph A Defronzo
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

Review 3.  Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism.

Authors:  Thomas Scherer; Christoph Buettner
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

4.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  Novel noninvasive breath test method for screening individuals at risk for diabetes.

Authors:  E Lichar Dillon; Morteza Janghorbani; James A Angel; Shanon L Casperson; James J Grady; Randall J Urban; Elena Volpi; Melinda Sheffield-Moore
Journal:  Diabetes Care       Date:  2008-12-15       Impact factor: 19.112

6.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

Review 7.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

8.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

Authors:  P Knudsen; J Eriksson; S Lahdenperä; J Kahri; L Groop; M R Taskinen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

9.  Free fatty acids inhibit TM-EPCR expression through JNK pathway: an implication for the development of the prothrombotic state in metabolic syndrome.

Authors:  Wanmu Xie; Zhenguo Zhai; Yuanhua Yang; Tuguang Kuang; Chen Wang
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

Review 10.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.